Milestone Scientific (MLSS) Cash & Equivalents (2016 - 2025)
Milestone Scientific (MLSS) has disclosed Cash & Equivalents for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.
- Quarterly Cash & Equivalents fell 66.67% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 66.67% year-over-year, with the annual reading at $1.1 million for FY2025, 66.67% down from the prior year.
- Cash & Equivalents hit $1.1 million in Q4 2025 for Milestone Scientific, down from $1.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $17.0 million in Q1 2021 to a low of $1.1 million in Q4 2025.
- Historically, Cash & Equivalents has averaged $7.0 million across 5 years, with a median of $4.4 million in 2024.
- Biggest five-year swings in Cash & Equivalents: soared 2112.96% in 2021 and later plummeted 82.81% in 2023.
- Year by year, Cash & Equivalents stood at $14.8 million in 2021, then plummeted by 40.97% to $8.7 million in 2022, then plummeted by 65.83% to $3.0 million in 2023, then increased by 10.82% to $3.3 million in 2024, then plummeted by 66.67% to $1.1 million in 2025.
- Business Quant data shows Cash & Equivalents for MLSS at $1.1 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.